Published in Heart Fail Rev on March 16, 2007
β2-Adrenergic receptor desensitization in perirenal adipose tissue in fetuses and lambs with placental insufficiency-induced intrauterine growth restriction. J Physiol (2010) 0.92
Developmental programming in response to intrauterine growth restriction impairs myoblast function and skeletal muscle metabolism. J Pregnancy (2012) 0.91
Exercise training initiated after the onset of diabetes preserves myocardial function: effects on expression of beta-adrenoceptors. J Appl Physiol (1985) (2008) 0.88
β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade. Am J Physiol Cell Physiol (2015) 0.85
The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus. J Signal Transduct (2013) 0.81
The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes. Int J Endocrinol (2015) 0.81
Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction. Cardiovasc Diabetol (2014) 0.80
PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell (2000) 10.25
Towards a molecular understanding of adaptive thermogenesis. Nature (2000) 7.04
Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Diabetes, hypertension, and cardiovascular disease: an update. Hypertension (2001) 4.62
Molecular characterization of the human beta 3-adrenergic receptor. Science (1989) 4.13
Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res (2006) 3.27
International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev (1994) 3.26
Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev (1998) 3.23
Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest (2003) 3.15
The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res (2000) 2.99
Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A (2001) 2.52
Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein. Circulation (1999) 2.50
Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev (1999) 2.38
Functional beta3-adrenoceptor in the human heart. J Clin Invest (1996) 2.32
Obesity and heart failure--risk factor or mechanism? N Engl J Med (2002) 2.22
Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev (1991) 2.09
Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest (1988) 1.85
The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol (1989) 1.80
Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol (1979) 1.79
The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest (1998) 1.66
beta(3)-Adrenoceptor agonists: potential, pitfalls and progress. Eur J Pharmacol (2002) 1.66
Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res (1994) 1.66
Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration. Diabetes (1974) 1.63
Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation (2001) 1.58
Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium. Circ Res (1990) 1.57
Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology. Naunyn Schmiedebergs Arch Pharmacol (2001) 1.53
G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling. J Biol Chem (1999) 1.49
Recent advances in cardiac beta(2)-adrenergic signal transduction. Circ Res (1999) 1.49
Why does the myocardium fail? Insights from basic science. Lancet (1998) 1.35
Characterization of the human beta 3-adrenergic receptor gene. Mol Pharmacol (1993) 1.33
beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther (2006) 1.32
A study designed to explore the hypothesis that beta-1 adrenoceptors are "innervated" receptors and beta-2 adrenoceptors are "hormonal" receptors. J Pharmacol Exp Ther (1981) 1.30
The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circ Res (1999) 1.28
(-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice. Mol Pharmacol (1998) 1.26
The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts. Diabetes (2001) 1.26
Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. Circulation (1993) 1.24
The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res (1992) 1.20
Adrenergic nervous system in heart failure. Am J Cardiol (1997) 1.16
Identification of the sites phosphorylated by cyclic AMP-dependent protein kinase on the beta 2 subunit of L-type voltage-dependent calcium channels. Biochemistry (1999) 1.16
Beta-adrenoceptor subtypes in human, rat, guinea pig, and rabbit atria. J Cardiovasc Pharmacol (1985) 1.15
Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J (1999) 1.09
Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown. J Clin Invest (2001) 1.05
Beta-adrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol (1999) 1.04
Insulin resistance in chronic heart failure. Eur Heart J (1994) 1.04
Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res (1986) 1.02
Beta3-adrenoceptors in the cardiovascular system. Trends Pharmacol Sci (2000) 1.02
Human myocardial beta-adrenoceptors: demonstration of both beta 1- and beta 2-adrenoceptors mediating contractile responses to beta-agonists on the isolated right atrium. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.02
Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol (1987) 1.02
Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev (1996) 1.01
beta-Adrenergic receptor decrease in diabetic rat hearts. Life Sci (1980) 0.97
Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization. Mol Cell Biochem (1996) 0.95
Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation. J Pharmacol Exp Ther (1997) 0.92
Heart failure and the ryanodine receptor: does Occam's razor rule? Circ Res (2002) 0.90
Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery. J Cardiovasc Pharmacol (1987) 0.87
Decreased beta-adrenergic receptors in rat heart in streptozotocin-induced diabetes: role of thyroid hormones. Endocrinology (1984) 0.87
Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes (1988) 0.87
Potential use of beta(3)-adrenoceptor antagonists in heart failure therapy. Cardiovasc Drug Rev (2002) 0.86
Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart. Br J Pharmacol (2002) 0.85
Diabetes-induced down-regulation of beta1-adrenoceptor mRNA expression in rat heart. Biochem Pharmacol (1999) 0.85
The effects of diabetes on beta-adrenoceptor mediated responsiveness of human and rat atria. Diabetes Res Clin Pract (1998) 0.85
Place of beta 3-adrenoceptors among other beta-adrenoceptor subtypes in the regulation of the cardiovascular system. Arch Mal Coeur Vaiss (2003) 0.84
beta-Adrenergic receptors, adenylate cyclase activity, and cardiac dysfunction in the diabetic rat. J Cardiovasc Pharmacol (1985) 0.83
The alpha 1-subunit of skeletal muscle L-type Ca channels is the key target for regulation by A-kinase and protein phosphatase-1C. Biochem Biophys Res Commun (1994) 0.82
Diabetic cardiomyopathy: where are we 40 years later? Can J Cardiol (2006) 0.82
The negative inotropic action of catecholamines: role of beta3-adrenoceptors. Can J Physiol Pharmacol (2000) 0.82
The beta 3-adrenergic system and beta 3-adrenergic agonists. Rev Endocr Metab Disord (2001) 0.81
Effects of beta-adrenoceptor stimulation on contractility, [Ca2+]i, and Ca2+ current in diabetic rat cardiomyocytes. Am J Physiol (1998) 0.81
Cardiac autonomic receptors: effect of long-term experimental diabetes. J Pharmacol Exp Ther (1984) 0.81
Effect of experimental diabetes on isolated rat heart responsiveness to isoproterenol. Can J Physiol Pharmacol (1984) 0.81
[Common variants in beta 3-adrenergic-receptor and uncoupling protein-2 genes are associated with type 2 diabetes and obesity]. Zhonghua Yi Xue Za Zhi (2004) 0.81
Altered inotropic responses in diabetic cardiomyopathy and hypertensive-diabetic cardiomyopathy. J Pharmacol Exp Ther (1991) 0.80
The effects of glyburide and insulin on the cardiac performance in rats with non-insulin-dependent diabetes mellitus. Gen Pharmacol (1993) 0.76
Beta 3-adrenoreceptor gene polymorphism: a newly identified risk factor for proliferative retinopathy in NIDDM patients. Diabetes (1997) 0.75
Thyroid hormones mediated effect of insulin on alloxan diabetic rat atria. Gen Pharmacol (1990) 0.75
Attenuation of changes in G(i)-proteins and adenylyl cyclase in heart failure by an ACE inhibitor, imidapril. J Cell Mol Med (2003) 0.75
Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage. Mol Cell Biochem (2004) 0.84
Cardioprotective effects of 44Bu, a newly synthesized compound, in rat heart subjected to ischemia/reperfusion injury. Eur J Pharmacol (2010) 0.81
Role of beta-3-adrenoceptor in catecholamine-induced relaxations in gastric fundus from control and diabetic rats. Pharmacology (2007) 0.81
Mechanisms of cardiodepression by an Na+-H+ exchange inhibitor methyl-N-isobutyl amiloride (MIA) on the heart: lack of beneficial effects in ischemia-reperfusion injury. Can J Physiol Pharmacol (2007) 0.79
Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage. Am J Physiol Heart Circ Physiol (2013) 0.79
Intracellular transactivation of epidermal growth factor receptor by α1A-adrenoceptor is mediated by phosphatidylinositol 3-kinase independently of activation of extracellular signal regulated kinases 1/2 and serine-threonine kinases in Chinese hamster ovary cells. J Pharmacol Exp Ther (2013) 0.78
The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts. Can J Physiol Pharmacol (2007) 0.76
Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells. Can J Physiol Pharmacol (2012) 0.75